ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0041991 | A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. | Uridine Diphosphoglucuronic Acid|Uridine diphosphate glucuronic acid (substance)|UDP Glucuronic Acid|Uridine diphosphate glucuronic acid|alpha-D-Glucopyranuronic acid, 1-P'-ester with uridine 5'-(trihydrogen diphosphate)|Glucuronic Acid, UDP|Acid, Uridine Diphosphoglucuronic|Diphosphoglucuronic Acid, Uridine|UDPGA|UDP glucuronic acid|Acid, UDP Glucuronic | Uridine Diphosphate Glucuronic Acid |
C0041991 | A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. | Uridine Diphosphoglucuronic Acid|Uridine diphosphate glucuronic acid (substance)|UDP Glucuronic Acid|Uridine diphosphate glucuronic acid|alpha-D-Glucopyranuronic acid, 1-P'-ester with uridine 5'-(trihydrogen diphosphate)|Glucuronic Acid, UDP|Acid, Uridine Diphosphoglucuronic|Diphosphoglucuronic Acid, Uridine|UDPGA|UDP glucuronic acid|Acid, UDP Glucuronic | Uridine Diphosphate Glucuronic Acid |
C0028351 | Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. | l-Norepinephrine|noradrenalin|(R)-noradrenaline|(-)-noradrenaline|Noradrenalin|1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-|Levarterenol|Norepinefrina|Arterenol|Norepinephrinum|Norepinephrine-containing product|Product containing norepinephrine (medicinal product)|NOREPINEPHRINE|(R)-(-)-norepinephrine|Noradrenaline-containing product|(-)-norepinephrine|Norepinephrine preparation|(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol|(-)-alpha-(aminomethyl)-3,4-dihydroxybenzyl Alcohol|l-3,4-Dihydroxyphenylethanolamine|(R)-norepinephrine|(-)-arterenol|levarterenol|Noradrenaline|Norepinephrine|Nor-adrenaline|Norépinéphrine|Levonorepinephrine|Norepinephrine (substance)|L-Norepinephrine|(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol|l-Noradrenaline|l-Arterenol|L-noradrenaline|noradrenaline|4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|Noradrenaline preparation|norepinephrine|norepinephrines | norepinephrine |
C0345274 | null | Complete duplication of appendix (disorder) | Complete duplication of appendix |
C0345274 | null | Complete duplication of appendix (disorder) | Complete duplication of appendix |
C0345274 | null | Complete duplication of appendix (disorder) | Complete duplication of appendix |
C0301817 | null | prohormones|Prohormone (substance)|Hormone precursor|prohormone|Hormone precursor (substance)|Prohormone|Prohormone, NOS | Prohormone (substance) |
C0524892 | DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organized similarly to the TcR beta-chain locus. | Gene, TcR gamma|T-Cell Receptor gamma-Chain Genes|T-Cell Rearranging Gene, Gamma|TcR gamma Genes|T-Cell Receptor Gamma Locus|TCRG|T-cell rearranging gene, gamma|T-Cell Receptor gamma Genes|T-cell receptor, gamma cluster|Genes, TcR gamma|T Cell Receptor gamma Chain Genes|Genes, T Cell Receptor gamma|T-cell antigen receptor, gamma polypeptide|T-Cell Receptor, Gamma Cluster|T cell receptor gamma locus|T-cell receptor gamma-chain gene|T-Cell Receptor Gamma Gene|TRG gene|T Cell Receptor gamma Genes|TcR gamma Gene|Genes, T-Cell Receptor gamma|TRG | TRG gene |
C0036945 | Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. | sheeps|ovi|Genus Ovis|ovis|Ovine (qualifier value)|Genus Ovis (organism)|lambs|sheep|SHEEP|Ovis, NOS|Ovis|Ovine|lamb|Sheep|ovine | Sheep |
C1552154 | <p>Supernumerary maxillary left second primary molar</p> | null | Js |
C0005773 | The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. | Corpuscle, Blood|Corpuscles, Blood|Peripheral blood cell|Blood cell, NOS|Peripheral Blood Cell|blood cells|Blood cell (cell)|Cell, Blood|Cells, Blood|blood cell|Blood Corpuscles|Blood Cells|Blood Corpuscle|Blood cells|blood corpuscles|Blood Cell|Blood cell | Blood Cells |
C0018492 | null | hagfish | Hagfish |
C0022990 | Common name for the only family (Petromyzontidae) of eellike fish in the order Petromyzontiformes. They are jawless but have a sucking mouth with horny teeth. | Lamprey Eels|FAMILY PETROMYZONTIDAE - LAMPREYS|Lamprey|Eels, Lamprey|Petromyzontidae|Lamprey Eel|Family Petromyzontidae - lamprey (organism)|Eel, Lamprey|Family Petromyzontidae - lamprey|Lampreys|lamprey | Lampreys |
C0034788 | Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens. | Antigen receptor (substance)|Antigen receptor site|Native Antigen Receptor|Antigen Receptors|antigen receptor|antigen receptors|Antigen receptor|Antigen Receptor|Receptor, Antigen | Receptors, Antigen |
C0034897 | To come back or to return. | recurrence|Recurrence|recurring|Recurrence (qualifier value)|recuring|recur|recurrences|recurs|recurred | Recurrence |
C0772448 | null | bovine collagen|Bovine collagen (substance) | Bovine collagen |
C0019120 | Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. | Haemostatic agent|Hemostatic drug|hemostatics|hemostatic|haemostatics|Anti-Hemorrhagic Agent|Antihemorrhagic|Hemostatic agent|Hemostatic agent (physical object)|drugs haemostatic|Haemostatic drug, NOS|hemostatic agent|agents hemostatic|Hemostatic agent, NOS|Hemostatic Agent|Haemostatic agent, NOS|haemostatic|hemostatic agents|substances that stop bleeding|Hemostatic drug, NOS|Hemostatic agent (substance)|Hemostatic|Hemostatics|Medicinal product acting as hemostatic (product) | Hemostatic Agents |
C0040892 | A parasite of carnivorous mammals that causes TRICHINELLOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae. | trichinella spiralis|Trichina spiralis|Trichina spirali|Trichinella spiralis|spiralis, Trichinella|spiralis, Trichina|Trichinella spiralis (organism)|Trichinella spirali|spiralis trichinella|TRICHINELLA SPIRALIS | Trichinella spiralis |
C0282774 | diamine oxidase and nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications. | Guanyl hydrazine|hydrazinecarboximidamide|Hydrazinecarboximidamide|PIMAGEDINE|Pimagedine|pimagedine|monoaminoguanidine|Aminate base|Monoaminoguanidine|aminoguanidine|Aminoguanidine | pimagedine |
C0322197 | A species of tapeworm in the family Hymenolepididae with a long cylindrical body, 4 suckers, and an apical organ at its scolex with no rostellar hooks. The lifecycle of H. diminuta involves beetles as the intermediate host and rodents as the definitive host. This tapeworm is prevalent in tropical zones worldwide but only rarely infects humans. | HYMENOLEPIS DIMINUTA|Tapeworm, Rat|Hymenolepis diminuta|Tapeworms, Rat|Hymenolepis diminutas|rat tapeworm|Rat Tapeworm|diminuta, Hymenolepis|Hymenolepis diminuta (organism)|Rat tapeworm|Rat Tapeworms | Rat tapeworm |
C0027028 | One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38) | Myenteric nerve plexus|Myenteric plexus|Remak's plexus|Plexus, Myenteric|Plexus nervosus myentericus|Myenteric Plexus|Meissner's plexus|Auerbach's Plexus|Auerbach's plexus|Submucous nerve plexus|Structure of Auerbach plexus|Plexus myentericus|Plexus submucosus|Myenteric Nerve Plexus|Auerbachs Plexus|auerbach plexus|Plexus, Auerbach's|Structure of Auerbach's plexus|Plexus nervosus submucosus|Submucous plexus|Structure of Auerbach's plexus (body structure)|myenteric plexus|Auerbach Plexus | Myenteric Plexus |
C0009022 | A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts. | Chinese liver fluke|Clonorchis sinenses|Oriental liver fluke|chinese liver fluke|Opisthorchis sinenses|CLONORCHIS SINENSIS|oriental liver fluke|Chinese Liver Fluke|Clonorchis sinensis|sinensis, Clonorchis|clonorchis sinensis|Clonorchis sinensis (organism)|sinenses, Opisthorchis|Opisthorchis sinensis | Clonorchis sinensis |
C0001911 | A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38) | Albendazole|Albendazole-containing product|ALBENDAZOLE|Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester|Product containing albendazole (medicinal product)|Albendazole (substance)|Albendazol|5-(propylthio)-2-carbomethoxyaminobenzimidazole|albendazole|Carbamic acid, (5-(propylthio)-1H-benzimidazol-2-yl)-, methyl ester|O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate|Albendazolum|(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester | albendazole |
C0025872 | A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. | metroNIDAZOLE|METRONIDAZOLE|Metronidazole-containing product|1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole|Metronidazolum|Metronidazole|2-Methyl-5-nitroimidazole-1-ethanol|Product containing metronidazole (medicinal product)|2-methyl-5-nitroimidazole-1-ethanol|2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole|2 Methyl 5 nitroimidazole 1 ethanol|1H-Imidazole-1-ethanol, 2-methyl-5-nitro-|Métronidazole|1-(β-oxyethyl)-2-methyl-5-nitroimidazole|1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole|Metronizole|1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole|metronidazole|Metronidazole (substance)|1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole|2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole|Metronidazol | metronidazole |
C0327237 | null | Trachydosaurus rugosus (organism)|Trachydosaurus rugosus|Shingleback|Tiliqua rugosa | Trachydosaurus rugosus |
C0039663 | A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. | 9 ene Tetrahydrocannabinol|delta(1)-THC|Delta-9-THC|1-trans-delta-9-Tetrahydrocannabinol|Delta9-THC|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol|Δ9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(9)-Tetrahydrocannabinol|dronabinol|Delta-9-tetrahydrocannabinol|Delta-9-Tetrahydrocannabinol|delta(1)-tetrahydrocannabinol|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|delta 9-tetrahydrocannabinol|Tetrahydrocannabinol|(-)-.DELTA.9-Tetrahydrocannabinol|tetrahydrocannabinol|Dronabinol (substance)|Dronabinolum|tetrahydrocannabinol (THC)|delta9-tetrahydrocannabinol|delta(9)-THC|Synthetic delta-9-Tetrahydrocannabinol|Product containing dronabinol (medicinal product)|Tetrahydrocannabinol (substance)|delta-9-Tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|Delta 9-Tetrahydrocannabinol|9-ene-Tetrahydrocannabinol|Delta-9-tetrahydrocannabinol (substance)|Dronabinol-containing product|DRONABINOL|Dronabinol|(-)-delta9-trans-Tetrahydrocannabinol|Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|delta-9-THC|Delta(9)-Tetrahydrocannibinol|THC | dronabinol |
C0025148 | The lower portion of the BRAIN STEM. It is inferior to the PONS and anterior to the CEREBELLUM. Medulla oblongata serves as a relay station between the brain and the spinal cord, and contains centers for regulating respiratory, vasomotor, cardiac, and reflex activities. | Medulla oblongata|Medulla oblongata structure|Bulbus|Medulla Oblongata|Medullary|Myelencephalon|Medulla Oblongatas|bulbus|myelencephalon|Medulla oblongata structure (body structure)|Medulla oblongata, NOS|medulla|Bulb|MEDULLA OBLONGATA|medulla oblongata|Metepencephalon|BRAIN, MEDULLA OBLONGATA | Medulla Oblongata |
C0039482 | Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region. | TEMPORAL ARTERY|temporal arteri|arteries temporal|Temporal Arteries|artery temporal|arteris temporal|Temporal Artery|Temporal artery|Arteries, Temporal|temporal artery|temporal arteries|Artery, Temporal | Temporal Arteries |
C0042755 | Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs. | MASCULINIZATION|Virilism|VIRILIZATION|Masculinization, NOS|Virilization, NOS|virilisation|Virilisation|virilization|Masculinization|masculinization|Virilization (finding)|Virilization|virilism|VIRILISM|Masculinisation|Abnormal Virilization | Abnormal Virilization |
C0001627 | A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. | Congenital adrenal hyperplasia (disorder)|Congenital Adrenal Hyperplasia|CONGENITAL ADRENAL HYPERPLASIA|Congenital Adrenal Gland Hyperplasia|Congenital adrenal hyperplasia|Hyperplasias, Congenital Adrenal|Adrenal Hyperplasia|hyperplasia adrenal congenital|Adrenal hyperplasia syndrome, congenital|ADRENAL HYPERPLASIA, CONGENITAL|adrenal congenital hyperplasia|congenital adrenal hyperplasia|CAH - Congenital adrenal hyperplasia|Hyperplasia, Congenital Adrenal|Congenital adrenogenital syndrome|Adrenogenital Syndrome|Adrenal Hyperplasias, Congenital|hyperplasia congenital adrenal|Adrenogenital Disorder|Congenital adrenal hyperplasia, NOS|Adrenal Hyperplasia, Congenital|Congenital Adrenal Hyperplasias | Congenital adrenal hyperplasia |
C0149676 | A finding in which there is a subnormal amount of an enzyme. Enzymes are proteins that are necessary in certain catabolic processes. | deficiency enzyme|ENZYME DEFICIENCY|deficiency enzymes|Enzyme Deficiency|Specific enzyme deficiency (disorder)|deficiencies enzyme|enzyme deficiency|deficiencies enzymes|Specific Enzyme Deficiency|Specific enzyme deficiency | Enzyme Deficiency |
C0002499 | A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. | amikacin|Amikacinum|Product containing amikacin (medicinal product)|Amikacin-containing product|Amikacin (substance)|AMIKACIN|AMIKA|Amikacina|Amikacin|1-N-(L(-)-γ-amino-α-hydroxybutyryl)kanamycin A|Amikacine|D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- | amikacin |
C0006205 | A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis. | Broad uterine ligament|Ligaments, Broad|uterine broad ligament|Broad ligament|Ligament, Broad|Broad ligament of uterus|Ligamentum latum uteri|broad ligament|Broad ligament structure (body structure)|Broad Ligament|Broad ligament, NOS|Lateral Ligament|Broad Ligaments|Broad ligament structure|broad ligaments | Broad Ligament |
C1281196 | null | Entire right ovary (body structure)|Entire right ovary | Entire right ovary |
C0446497 | null | RIF - Right iliac fossa|right iliac fossa|Right iliac fossa|Right iliac fossa (body structure)|fossa iliac right | Right iliac fossa |
C0456765 | null | teres|Teres (body structure) | Teres |
C1300127 | A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002). | Perivascular epithelial cell tumour|PEComas|neoplasm with perivascular epithelioid cell differentiation|tumor with perivascular epithelioid cell differentiation|pecomas|Perivascular epithelioid cell tumor|Perivascular Epithelioid Cell Tumors|Neoplasms, Perivascular Epithelioid Cell|pecoma|Perivascular epithelioid cell tumour|Tumor with Perivascular Epithelioid Cell Differentiation|PEComa|Perivascular epithelial cell tumor|Perivascular epithelioid cell tumor (morphologic abnormality)|Neoplasm with Perivascular Epithelioid Cell Differentiation | Perivascular Epithelioid Cell Neoplasms |
C0162324 | null | gallus, Ascaridia|Ascaridia galli|Ascaris galli|Ascaridia gallus|Ascaridia galli (organism) | Ascaridia galli |
C0162324 | null | gallus, Ascaridia|Ascaridia galli|Ascaris galli|Ascaridia gallus|Ascaridia galli (organism) | Ascaridia galli |
C0524983 | A gastrin-producing enteroendocrine cell that is located in the gastric antrum. | Type G enteroendocrine cell|Gastrin Secreting Cell|Gastrin-Secreting Cell|Cell, Gastrin-Secreting|g cells|G cell|Gastrin secreting cell|g cell|Gastrin Secreting Cells|G Cell|Gastrin Cells|G-Cell|Gastrin Cell|G Cells|Cells, Gastrin-Secreting | Gastrin-Secreting Cells |
C1269048 | null | Entire temporomandibular joint (body structure)|Entire temporomandibular joint|Entire TMJ - Temporomandibular joint | Entire temporomandibular joint |
C0006669 | A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. | Calcitonin gene-related peptide (substance)|Calcitonin gene related peptide|calcitonin gene related peptide (CGRP)|Calcitonin Gene Related Peptide|LAB CGRP|CGRP|cgrp|Gene-Related Peptide, Calcitonin|Calcitonin Gene-Related Peptide|Calcitonin gene-related peptide|Calcitonin-gene-related peptide|calcitonin gene related peptide | Calcitonin Gene-Related Peptide |
C1003469 | null | null | Holothuria glaberrima |
C0229889 | Tubular vessels that are involved in the transport of LYMPH and LYMPHOCYTES. | Vessel, Lymphatic|Lymphatic vessel|Lymphatic, NOS|Set of lymphatic vessels|Lymphatic vessels|lymph vessels|Lymphatic trunks and ducts|Trunci et ductus lymphatici|Lymphatic vessels set|Structure of lymphatic vessel|Vessels, Lymphatic|Structure of lymphatic vessel (body structure)|Lymphatic vessel, NOS|Lymph vessel|VESSEL, LYMPHATIC|lymphatic vessel|Lymphatics|Lymphatic Vessels|lymph vessel|Vas lymphaticum|lymphatic vessels|Lymphatic Vessel|Lymphatic | Lymphatic vessel |
C0228013 | One of 12 to 14 small seminal ducts leading from the testis to the head of the epididymis. | Structure of efferent ductule of testis|Efferent ductule|Efferent Ductule|Structure of efferent ductule of testis (body structure)|Efferent ductules|Efferent ductules set|Efferent ductule of testis|DUCT, EFFERENT|Efferent Duct|Ductuli efferentes testis|Set of efferent ductules | Structure of efferent ductule of testis |
C0332463 | null | Narrowed structure (morphologic abnormality)|narrow|narrowing|Narrowed structure|Narrow|Narrowing, NOS|Narrowing | Narrowed structure |
C0228023 | The first region of the epididymis distal to the testis. | Epididymis head|Epididymal head|Head of the Epididymis|Structure of head of epididymis (body structure)|Structure of head of epididymis|epididymal head|Caput epididymidis|Head of epididymis | Head of epididymis |
C0033774 | An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. | Itch of skin|Skin Pruritus|Excessive scratching|Itchy|Pruritus NOS|itchy|Pruritus, NOS|Unspecified pruritic disorder|PRURITUS|Pruritus of skin|pruritic dermatitis|Itchy skin|Pruritic Disorder|itch|Pruritic dermatitis, NOS|ITCHING|pruritis|skin itching|Pruritic disorder|pruritus|Itch of skin, NOS|Skin itching|Itch NOS|Pruritic disorder (disorder)|Itch of skin (observable entity)|itch skin|Pruritus|skin itch|Itching (pruritus)|itchy skin|Itching (finding)|Pruritus of skin, NOS|Itching of skin (finding)|Pruritis|itching skin|Pruritic dermatitis|Scratching skin|PRURITIS|Itch|itching|Itching of skin|Pruritus - disorder|Itching | Pruritus |
C1045029 | null | null | Cobitis taenia |
C1516974 | The estrogen receptor level measured in a primary tumor or in metastases. There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and is characterized by an ER+ status. However, these two variants tend to overlap with respect to age, so it is possible for a young woman to have a "late-onset" form of breast cancer and for an older woman to have an "early-onset" variant of the disease. | ERA Status|Estrogen Receptor Status|Estrogen Receptor Alpha Status|ER Status|NR3A1 Status|ESR1 Status|ER-Alpha Status|Estrogen Receptor 1 Status|ESR Status|ESRA Status|ER Alpha Status|ESTRR Status|Nuclear Receptor Subfamily 3 Group A Member 1 Status | Estrogen Receptor Status - Clinical Trial Eligibility Criteria |
C0009835 | Arrest of cell locomotion or cell division when two cells come into contact. | Inhibition, Contact|contact inhibition|Inhibitions, Contact|Contact Inhibitions | Contact Inhibition |
C0912024 | 5,7,4'-trihydroxy-flavone, one of the FLAVONES. | APIGENIN|Flavone, 4',5,7-trihydroxy-|5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one|4',5,7-trihydroxyflavone|5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone|2-(p-hydroxyphenyl)-5,7-dihydroxychromone|Apigenin | apigenin |
C0912024 | 5,7,4'-trihydroxy-flavone, one of the FLAVONES. | APIGENIN|Flavone, 4',5,7-trihydroxy-|5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one|4',5,7-trihydroxyflavone|5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone|2-(p-hydroxyphenyl)-5,7-dihydroxychromone|Apigenin | apigenin |
C0071011 | Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. | phytoestrogens|Plant Estrogens|Phytoestrogen|Phytoestrogens|Phyto Estrogen|Phyto-Estrogen|phytoestrogen|phyto estrogens|phyto estrogen|phyto-estrogen|Estrogens, Plant|Plant Estrogen|Estrogen, Plant | Phytoestrogens |
C0007595 | The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. [GOC:ai] | cell expansion|cell growth|growth of cell|Cells--Growth|Cellular Expansion|cellular growth|Cell Growth|cell growths|Cellular Growth|growth cell|cells growth | Cell Growth |
C0087071 | An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. | Telomerase|Telomerase Reverse Transcriptase|Transcriptase, Telomerase Reverse|Reverse Transcriptase, Telomerase|telomerase | Telomerase |
C0730333 | null | Tamoxifen retinopathy (disorder) | Tamoxifen retinopathy |
C1550278 | null | Medullary | Medullary - body parts |
C1513959 | null | null | Neoplastic Epithelial Cell |
C0014912 | The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. | 17 beta-estradiol|17-beta-Estradiol|therapeutic estradiol|E2 - estradiol|17 beta Estradiol|Estradiolum|17β-oestradiol|17beta oestradiol|(17beta)-estra-1,3,5(10)-triene-3,17-diol|17-beta estradiol|estradiols|17-beta oestradiol|17β-estradiol|17 beta-Oestradiol|17 beta-Estradiol|17 beta Oestradiol|ESDL|cis-Estradiol|Product containing estradiol (medicinal product)|Estradiol-containing product|Estradiol 17 beta|Estradiol-17beta|Estradiol|Estradiol (E2)|Estra-1,3,5(10)-triene-3,17-diol (17beta)-|ESTRADIOL 17-BETA|beta-Estradiol|(17β)-estra-1,3,5(10)-triene-3,17-diol|Estradiol (substance)|17 beta estradiol|17beta estradiol|17β-estra-1,3,5(10)-triene-3,17-diol|Estraldine|ESTRADIOL|Oestradiol|Estradiol-17 beta|estradiol|oestradiol|17 Beta-Estradiol|Estradiol 17beta|Estradiol preparation|Estradiol Anhydrous|(17beta)-Estra-1,3,5(10)-triene-3,17-diol | estradiol |
C0520759 | null | Carcinogen effect, NOS|Carcinogen effect (disorder) | Carcinogen effect |
C1174777 | null | Somavert | Somavert |
C0913469 | A pegylated, recombinant, human growth hormone (GH) structural analog with GH receptor antagonist activity. As a GH analog, the structure of pegvisomant is similar to that of native GH with the exception of 9 amino acid substitutions. Pegvisomant selectively binds to GH receptors on cell surfaces, interfering with endogenous GH receptor binding and so GH signal transduction. Inhibition of GH signal transduction results in decreased serum concentrations of insulin-like growth factor-I (IGF-I), and other GH-responsive serum proteins, including IGF binding protein-3 (IGFBP-3) and the acid-labile subunit (ALS), and may inhibit the growth of cancers in which IGF-1 is upregulated. | pegvisomant|PEGVISOMANT|Somatotropin (18-Aspartic Acid, 21-Asparagine, 120-Lysine, 167-Asparagine, 168-Alanine, 171-Serine, 172-Arginine, 174-Serine, 179-Threonine) (Human), Pegylated|Pegvisomant-containing product|Product containing pegvisomant (medicinal product)|Pegvisomant (substance)|Pegvisomant | pegvisomant |
C0037657 | Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. | Somatomedin|Insulin-Like Growth Factors|Insulin-Like Growth Factor|Factor, Sulfation|IGF|Somatomedins|Somatomedin-containing product|Factors, Insulin-Like Growth|Somatomedin (substance)|somatomedins|insulin like growth factors|Sulfation Factor|Insulin-like growth peptide|insulin-like growth factor|Somatomedin preparation|Product containing somatomedin (medicinal product)|insulin like growth factor|insulin-like growth factors|somatomedin|Insulin-like growth factor|Insulin Like Growth Factors|Growth Factors, Insulin-Like|insulinlike growth factor|factor growth insulin-like|Somatomedin, NOS | Somatomedins |
C0377265 | A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. | Etiracetam, S-isomer|1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-|1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-|Product containing levetiracetam (medicinal product)|Etiracetam, S isomer|S-isomer Etiracetam|(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide|Levetiracetamum|Levetiracetam|Levetiracetam (substance)|levetiracetam|(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide|Levetiracetame|LEVETIRACETAM|1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-|Levetiracetam-containing product|levETIRAcetam | levetiracetam |
C0377265 | A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. | Etiracetam, S-isomer|1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-|1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-|Product containing levetiracetam (medicinal product)|Etiracetam, S isomer|S-isomer Etiracetam|(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide|Levetiracetamum|Levetiracetam|Levetiracetam (substance)|levetiracetam|(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide|Levetiracetame|LEVETIRACETAM|1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-|Levetiracetam-containing product|levETIRAcetam | levetiracetam |
C0180309 | An arrhythmia detector and alarm is a system that monitors the electrocardiogram and is designed to produce a visible or audible signal or alarm when an atrial or ventricular arrhythmia, such as a premature contraction or ventricular fibrillation, exists. | automated external defibrillator (AED)|aeds|External Defibrillators, Automated|automatic external defibrillator|Defibrillators, Automated External|Automated External Defibrillators|External Defibrillator, Automated|DEFIBRILLATORS, AUTOMATIC, EXTERNAL|Automated External Defibrillator|Defibrillator, Automated External | Automated External Defibrillators |
C0018687 | Combination of HEALTH KNOWLEDGE, ATTITUDES, PRACTICE which underlie actions taken by individuals regarding their health. | behavior health|Health and Behavior|health behavior|Behaviors, Health|Behavior, Health|Health Behaviors|health behaviors|Health behavior|Health Behavior | Health behavior |
C0010641 | A multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. Deficiency of this enzyme leads to HYPERHOMOCYSTEINEMIA and HOMOCYSTINURIA. EC 4.2.1.22. | Synthetase, Cystathionine|Cystathionine Synthetase|L-Serine hydro-lyase (adding homocysteine)|Serine Sulfhydrase|Cystathionine beta-synthase|beta-Synthase, Cystathionine|cystathionine beta-synthase|Cystathionine beta-Synthase|cystathionine beta synthase|Cystathionine beta-synthase (substance)|Serine sulphydrase|serine sulfhydrase|Beta-thionase|beta-Thionase|Methylcysteine synthase|Sulfhydrase, Serine|Cystathionine synthetase|beta thionase|methylcysteine synthase|Serine sulfhydrase|Cystathionine beta Synthase|beta Thionase | Cystathionine beta-Synthase |
C0013080 | A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) | Trisomy 21|Down syndrome|47,XY,+21|Complete trisomy 21 syndrome (disorder)|Syndrome, Down|T21 - Trisomy 21|Complete trisomy 21 syndrome|TRISOMY 21 SYNDROME|TRISOMY 21|Down's Syndrome|Down's syndrome|21 trisomy|Down Syndrome|downing syndrome|Trisomy G|Downs Syndrome|MONGOLISM|mongolism|SYNDROME DOWN'S|down s syndrome|DOWN SYNDROME|mongoloidism|Downs syndrome|Trisomy 21 (morphologic abnormality)|Chromosomal imbalance syndrome, pair 21, trisomy|trisomy 21|G Trisomy|Trisomy 21 syndrome|47,XX,+21|Syndrome, Down's|21 trisomies|DOWN'S SYNDROME|trisomy 21 syndrome|morbus down|Mongolism|Trisomy 21 (Down Syndrome)|MONGOLOIDISM|Trisomy 21 Syndrome | Down Syndrome |
C0009240 | Intellectual or mental process whereby an organism obtains knowledge. | Cognition|Function, Cognitive|Cognition, NOS|cognition/thought processes|COGNITION|cognitions|Cognitive Functions|cognition|Cognitive Function|Cognitions|Functions, Cognitive | Cognition |
C0993564 | null | Acinonyx jubatus (organism)|acinonyx jubatus|Acinonyx jubatus|Cheetah|cheetah|Hunting leopard | Acinonyx jubatus |
C0014994 | A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes. | Ether|Ether, Diethyl|Ethyl ether|Ether-containing product|Ether (substance)|sulfuric ether|diethyl ether|Diethyl Ether|Ether solvent|Product containing ether (product)|Ethane, 1,1'-oxybis-|ethyl ether|ETHER|Ethyl Ether|Ether, Ethyl|ether | ethyl ether |
C1457867 | null | Phaseolus lunatus (organism)|Phaseolus limensis|Phaseolus viridis|Phaseolus lunatus|Lima bean | Phaseolus lunatus |
C1515430 | Tissue composed of a highly cellular outer cortex, and less cellular inner medulla. Both cortex and medulla contain epithelial cells, interdigitating dendritic cells, macrophages, and lymphocytes. | Thymic Tissue | Thymic Tissue |
C0772394 | A drug that inhibits blood clotting. It is being studied in cancer treatment. | Product containing lepirudin (medicinal product)|1-Leu-2-Thr-63-desulfohirudin|Lepirudin (substance)|Lepirudin-containing product|Hirudin variant-1|LEPIRUDIN|Recombinant Hirudin|Lepirudin recombinant|Lepirudin|lepirudin | lepirudin |
C0018824 | Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). | Diseases, Heart Valve|Heart Valve Disease|Heart valve disease, NOS|Heart valve disease|valvular heart diseases|Heart valve disorder|cardiac valve disorder|Valvular Heart Diseases and Syndromes|Heart Valve Diseases|Heart Diseases, Valvular|Diseases, Valvular Heart|Disorder of heart valve|heart valve disorder|Valvular heart disease, NOS|disease heart valvular|disease heart valves|valvular heart disease|Heart valve disorder (disorder)|heart valvular disease|Valvular Heart Disorder|Valvular heart disease or syndrome|valve heart disease|Valvulopathy|Heart valve disorder, NOS|Valve Diseases, Heart|Heart Valve Disorder|diseases heart valve|Disease, Valvular Heart|Heart Disease, Valvular|Disease, Heart Valve|heart valve disorders|heart valve diseases|Valve Disease, Heart|disease heart valve|HEART VALVE DISORDERS|Disorder of Heart Valve|Valvular heart disease|VALVULAR HEART DISEASE|Valvular Heart Disease|disorders heart valve|cardiac valvular disease|Heart valve disorders|Heart valves--Diseases|cardiac valvulopathy|Cardiac valve disease|Valvular Heart Diseases|heart valve disease | Heart valve disease |
C0026268 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve. | MVR - Mitral valve replacement|mitral replacement valve|surgery mitral valve replacement|Replacement of mitral valve|mitral valve replacement surgery|Replacement of mitral valve (procedure)|Excision and replacement of mitral valve|mitral valve replacement|Mitral Valve Replacement|mitral replacements valve|Replacement of mitral valve, NOS|mitral valve repair replacement|replacement of mitral valve|MITRAL VALVE REPLACEMENT | Replacement of mitral valve (procedure) |
C0264686 | null | Coronary artery embolism (disorder)|Coronary embolism|Coronary artery embolism|Coronary embolus|EMBOLISM, CORONARY|EMBOLUS CORONARY ARTERY|CORONARY EMBOLISM | Coronary artery embolism |
C0225860 | One of four chambers of the heart, which receives blood from the pulmonary veins and pumps blood through the mitral valve into the left ventricle. | left atrium|Left atrial structure|LEFT ATRIUM|atrium left|Left Atrium of Heart|HEART, LEFT ATRIUM|Left atrium of heart|Atrium sinistrum|Left Atrium|Atrium cordis sinistrum|Left atrial structure (body structure)|Left sided atrium|Left sided atrium (body structure)|Left atrium, NOS|Atrium, Left|Left atrium | Left atrial structure |
C0025312 | Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. (From Joynt, Clinical Neurology, 1992, Ch55, pp35-6) | myelomeningocele|meningomyelocele|Myelomeningoceles|Myelocystocele|Meningomyelocele (disorder)|MENINGOMYELOCELE|Spina bifida cystica|myelomeningoceles|Meningomyeloceles|meningomyeloceles|Myelomeningocele|Meningomyelocele|Spina Bifida Cystica | Meningomyelocele |
C0027902 | Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. | Tests, Neuropsychological|Neuropsychological tests|Neuropsychologic Tests|Neuropsychological testing (procedure)|assessment neuropsychological|neuropsychological test|neuropsychological diagnosis|Test, Neuropsychological|neuropsychological testing|Neuropsychological Test|neuropsychologic tests|Neuropsychologic Test|neuropsychological tests|Neuropsychological testing|testing neuropsychological|neuropsychological assessment | Neuropsychological Tests |
C0392335 | null | Cognitive functions|Cognitive functions (observable entity)|cognitive function|cognitive functions | Cognitive functions |
C0870921 | null | null | motor performance |
C0053511 | null | N-carbamoyl-beta-alanine amidohydrolase|beta-Ureidopropionase|N-carbamoyl beta-alanine amidohydrolase|beta-alanine synthase|Beta-ureidopropionase (substance)|beta-ureidopropionase|Beta-ureidopropionase | beta-Ureidopropionase |
C0038220 | A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30) | status epilepticus|Generalized Status Epilepticus|Status epilepticus|Repeated seizures without recovery between them|STATUS EPILEPTICUS|Status Epilepticus|epilepticus status|Status epilepticus (disorder)|Status epilepticus NOS|Status Epilepticus, Generalized | Status Epilepticus |
C0543419 | A pathologic condition that results from a disease, treatment, or injury. | Residual|Sequela of disorder|Sequelae of disorders (disorder)|disease sequela|late effects|late effect|aftereffect|Pathologic Sequela|Sequelae of disorders|sequela|Sequela (disorder)|Sequelae|Disease Sequela|Sequela|aftereffects|effects late|sequelas | Sequela of disorder |
C1284115 | null | Entire cerebral white matter|Entire cerebral white matter (body structure) | Entire cerebral white matter |
C0238096 | Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE. | Paradoxical Embolism|EMBOLISM, PARADOXICAL|paradoxical embolism|Crossed Embolism|Paradoxical embolus|Paradoxical embolism|Paradoxical embolism (morphologic abnormality)|Embolisms, Crossed|Embolism, Crossed|Paradoxical Embolisms|Embolisms, Paradoxical|Crossed Embolisms|paradoxical embolus|embolism paradoxical | Embolism, Paradoxical |
C0016522 | A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance. | PFO - Patent foramen ovale|patent foraman ovale|FORAMEN OVALE PATENT|secundum atrial septal defect|Patent Foramen Ovale|Patent foramen ovale|patent foramen ovale|Patent foramen ovale (disorder)|Patent Oval Foramen|FORAMEN OVALE, PATENT|foramen ovale patent|patent foramen ovales|Foramen Ovale, Patent|Oval Foramen, Patent | Foramen Ovale, Patent |
C1267299 | null | Entire left middle cerebral artery|Entire left middle cerebral artery (body structure) | Entire left middle cerebral artery |
C0232827 | null | Urinary concentration, function|Urinary concentration|Urinary concentration, function (observable entity) | Urinary concentration |
C0085143 | Any method of measuring the amount of work done by an organism, usually during PHYSICAL EXERTION. Ergometry also includes measures of power. Some instruments used in these determinations include the hand crank and the bicycle ergometer. | ergometry|Ergometries|Ergometry | Ergometry |
C0025611 | A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. | (S)-N,α-dimethylbenzeneethanamine|Metamfetamine (substance)|Tina|methylamphetamine|methamphetamine|methyl-β-phenylisopropylamine|d-1-phenyl-2-methylaminopropane|N-Methylamphetamine|meth|(+)-(S)-N-α-dimethylphenethylamine|Metanfetamina|Methamphetamine|metamfetamine|Desoxyephedrine|Product containing metamfetamine (medicinal product)|deoxyephedrine|(αS)-N,α-dimethylbenzeneethanamine|d-deoxyephedrine|Ice|Methamphetaminum|ice [methamphetamine]|Deoxyephedrine|ice|Crystal|cranks|desoxyephedrine|METHAMPHETAMINE|Metamfetaminum|d-phenylisopropylmethylamine|Methylamphetamine|N Methylamphetamine|Benzeneethanamine, N,alpha-dimethyl-, (S)-|Chalk|Metamfetamine|Methamphetamine-containing product|Speed|d-desoxyephedrine|Métamfétamine|Meth|d-N-methylamphetamine|Glass|crank|Metamfetamine-containing product | methamphetamine |
C0085839 | null | Arm Ergometry Tests|Tests, Arm Ergometry|Test, Arm Ergometry|Ergometry Tests, Arm|Ergometry Test, Arm | Arm Ergometry Test |
C0163712 | null | relate|related|relates | Relate - vinyl resin |
C0016664 | Fractures due to the strain caused by repetitive exercise. They are thought to arise from a combination of MUSCLE FATIGUE and bone failure, and occur in situations where BONE REMODELING predominates over repair. The most common sites of stress fractures are the METATARSUS; FIBULA; TIBIA; and FEMORAL NECK. | Fracture, Fatigue|March fracture (disorder)|March fracture|Fracture, Stress|Fatigue Fractures|Fatigue fracture|Fatigue Fracture|FOOT, MARCH|FRACTURE, MARCH|stress fracture|Stress fracture (disorder)|March Fractures|Stress Fracture|March Fracture|Stress Fractures|FATIGUE FRACTURE|Stress fracture (morphologic abnormality)|Fracture, March|Fractures, Stress|Fatigue fractures|fatigue fracture|stress fractures|march fracture|Fractures, Fatigue|Stress fracture|Fractures, March|STRESS FRACTURE|march fractures | Stress Fractures |
C0205949 | The pattern of a person's emotional, romantic, and/or sexual attractions. | Sexual Orientation|Sexual orientation (observable entity)|sexual orientation|preferences sexual|Sexual Preference|Sexual orientation|Orientation, Sexual|orientation sexual|sexual preference|Sexual preference, NOS|Sex Orientation|Sexual orientation, NOS | Sexual Orientation |
C0871525 | null | therapists | therapist |
C0682906 | Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements. | transition elements|transition metal|Elements, Transition|Transition metals | Transition Elements |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.